A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

Shira Dinner, Tamara J. Dunn, Elizabeth Price, Steven E. Coutré, Jason Gotlib, Caroline Berube, Gregory P. Kaufman, Bruno C. Medeiros, Michaela Liedtke

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences